Daniel W. Lin

A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results

Steven B. Zeliadt, Peggy A. Hannon, Ranak B. Trivedi, 2013, BMC Medical Informatics and Decision Making.

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of D

Lawrence D. True, Beatrice S. Knudsen, Mark A. Rubin, 2014, Archives of pathology & laboratory medicine.

Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

Pär Stattin, Elaine A. Ostrander, Fredrik Wiklund, 2011, Cancer Epidemiology, Biomarkers & Prevention.

What Happens After an Elevated PSA Test: The Experience of 13,591 Veterans

Steven B. Zeliadt, Ruth Etzioni, Daniel W. Lin, 2010, Journal of General Internal Medicine.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IMPACT study

Yair Lotan, John L. Gore, Adam S. Kibel, 2017, Cancer.